Article

Short-term impact of a randomized multifaceted intervention for wheezing infants in low-income families.

National Jewish Medical and Research Center, University of Colorado Health Sciences Center, Denver 80206, USA.
Archives of Pediatrics and Adolescent Medicine (Impact Factor: 4.25). 02/2005; 159(1):75-82. DOI: 10.1001/archpedi.159.1.75
Source: PubMed

ABSTRACT To present an interim analysis of the effect of a home-based intervention with low-income caregivers of wheezing infants at risk for childhood asthma on mediating variables.
Infants aged 9 to 24 months with 3 or more physician-documented wheezing episodes were randomly assigned to environmental support intervention (ES) (n = 90) or control (n = 91) groups. Nurse home visitors intervened for 1 year to decrease allergen and environmental tobacco smoke exposure and improve symptom perception and management. Assessments at baseline and 12 months included allergens in house dust, infant urinary cotinine levels, caregivers' symptom reports, quality of life, illness management, and quality of caregiving. Medical records were coded for hospitalizations, emergency department visits, and corticosteroid bursts.
Within the ES group, cockroach allergen levels were significantly reduced and there was a trend toward reduction in dog dander levels. Among infants with detectable urinary cotinine, levels were significantly reduced in the ES group. Caregiver psychological resources modified the impact, and low-resource ES caregivers were the most strongly affected. Asthma knowledge and provider collaboration improved significantly in the ES group. Neither reports of infant symptoms nor emergency department visits or hospitalizations showed positive intervention effects. Number of corticosteroid bursts for infants was significantly higher for the ES group.
The Childhood Asthma Prevention Study intervention was effective in reducing several environmental exposures and improving illness management. However, even with an intensive home-based intervention, we failed to reduce respiratory symptoms or medical use in the ES group relative to the control group, illustrating the difficulty of changing the course of early asthma development among low-income infants.

0 Followers
 · 
92 Views
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: Worldwide, roughly 40% of children are exposed to the damaging and sometimes deadly effects of tobacco smoke. Interventions aimed at reducing child tobacco smoke exposure (TSE) have shown mixed results. The objective of this study was to perform a systematic review and meta-analysis to quantify effects of interventions aimed at decreasing child TSE. Data sources included Medline, PubMed, Web of Science, PsycNet, and Embase. Controlled trials that included parents of young children were selected. Two reviewers extracted TSE data, as assessed by parentally-reported exposure or protection (PREP) and biomarkers. Risk ratios and differences were calculated by using the DerSimonian and Laird random-effects model. Exploratory subgroup analyses were performed. Thirty studies were included. Improvements were observed from baseline to follow-up for parentally-reported and biomarker data in most intervention and control groups. Interventions demonstrated evidence of small benefit to intervention participants at follow-up (PREP: 17 studies, n = 6820, relative risk 1.12, confidence interval [CI] 1.07 to 1.18], P < .0001). Seven percent more children were protected in intervention groups relative to control groups. Intervention parents smoked fewer cigarettes around children at follow-up than did control parents (P = .03). Biomarkers (13 studies, n = 2601) at follow-up suggested lower child exposure among intervention participants (RD -0.05, CI -0.13 to 0.03, P = .20). Interventions to prevent child TSE are moderately beneficial at the individual level. Widespread child TSE suggests potential for significant population impact. More research is needed to improve intervention effectiveness and child TSE measurement.
    PEDIATRICS 03/2014; 133(4). DOI:10.1542/peds.2013-0958 · 5.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Allergic inflammation is correlated with the severity of ocular, nasal and bronchial symptoms. This inflammation results from the production of pro-inflammatory cytokines (interleukin-5, interferon-gamma, etc.) and from a deficient production of anti-inflammatory cytokines (interleukin-10, CC16, etc.), and develops very early during the course of allergic illnesses. A very early infection with respiratory syncytial virus is responsible for a Th2 response during reinfections, and may promote the development of asthma. In contrast, late infections are responsible for Th1 immune responses at the time of reinfections, and may reduce the asthmatic risk. The majority of serum specific IgE determinations are useless for prediction of the atopic and asthmatic risks in young children. Those risks can be determined by interview of the parents, clinical examination, functional respiratory tests and/or determination of nitric oxide in exhaled air. Interview of the parents and clinical examination at school have good positive and negative predictive values. Except for the prescription of inhalers, other preventive measures at school and home have not a long-term efficacy. Moderate to high doses of inhaled corticosteroids have an impact on the hypothalamo-pituitary-adrenocortical axis and long-term effects on bone metabolism. The leukotriene receptor antagonist, montelukast, reduces significantly allergic inflammation, bronchial hyperreactivity and asthma symptoms in children with mild to moderate asthma. However, inhaled corticosteroids are more effective than montelukast in children with moderate to severe asthma. Finally, sublingual immunotherapy is well-tolerated by children, including children below the age of 5 years. However, the efficacy and immunologic effects of sublingual immunotherapy are still controversial.
    Revue Française d Allergologie et d Immunologie Clinique 09/2006; 46(5):495-506. DOI:10.1016/j.allerg.2006.03.001 · 0.24 Impact Factor

Preview

Download
1 Download
Available from